Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Annovis Bio Inc
ANVS
Healthcare
Biotechnology
Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced...
small molecule, orally administered, brain penetrant compound. Its product candidate ANVS405 is an intravenous drug being developed for acute indications and focused on protecting the brain after traumatic brain injury (TBI) and/or stroke. ANVS405 is the same compound as Buntanetap, given in cases of acute head and brain trauma. ANVS301 is an orally administered drug being developed to increase cognitive capability in later stages of AD and dementia. ANVS301 is observed to improve memory and learning in very old rats by lowering the number of errors from six to three.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ANVS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Dec 29, 2021 12:53pm
Anyone buying here?
Looking for the bottom.
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jun 22, 2021 8:30am
ANVS 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!
5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jun 21, 2021 8:36am
CHEMOCENTRYX: A LOT RIDES ON THE APPROVAL OF AVACOPAN
$CCXI CHEMOCENTRYX: A LOT RIDES ON THE APPROVAL OF AVACOPAN
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jun 18, 2021 8:24am
CAN ANNOVIS BIO DELIVER A BREAKTHROUGH IN ALZHEIMER’S DISEAS
$ANVS CAN ANNOVIS BIO DELIVER A BREAKTHROUGH IN ALZHEIMER’S DISEASE? https://www.aviseanalytics.com/annovis-bio/
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 6:09pm
RE:ANVS......You've all been had ....again!!!!
This was planned out a few months ago....check it out. Here is the link to EDGAR.... EDGAR Entity Landing Page (sec.gov) This chit is done every day....you better do some research before you trade.
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 6:03pm
ANVS......You've all been had ....again!!!!
Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock 2021-05-21 14:16 PT - News Release Berwyn, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Annovis Bio, Inc. (NYSE
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 4:00pm
RE:ANVS.....long at the low here
LoL....sold at $60
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 3:45pm
ANVS.....long at the low here
Small position CHEERS
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 3:37pm
RE:RE:RE:ANVS....LoL
I told you....it would get Real Ugly
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 3:34pm
RE:RE:ANVS....LoL
Double Doh !! $58
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 3:32pm
RE:ANVS....LoL
Doh !!!!!!! $61
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 3:27pm
ANVS....LoL
I should have waited.... But profit is profit Cheers ! Currently at ~ $65 .... needs to hold $63 or it could get real ugly
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 3:17pm
ANVS.... That's enough excitement for me...
Done like dinner.... Cha -Ching Covered my short...... Cheers !!!!!!!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on May 21, 2021 3:04pm
RE:ANVS.....New target is......
I failed to mention ...i have a stop inplace if it goes against me. I will lock in profit...regardless
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 21, 2021 3:01pm
ANVS.....New target is......
Between 62.80 and 53.01 Wish me luck !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study